Volume 5, Number 8 (September 2007)

390

Conference Schedule

full text

54 kb

395

Educational Program Abstracts

full text

104 kb

401

Scientific Abstracts

full text

176 kb

Bench to Bedside

355

Malignant Gastroparesis: Pathogenesis and Management of an Underrecognized Disorder
Kavitha R. Donthireddy, MD, Sikander Ailawadhi, MD, Eiad Nasser, MD, Michael D. Schiff, MD, FACP, Chukwumere E. Nwogu, MD, Hector R. Nava, MD, and Milind M. Javle, MD

Department of Medicine and Surgery, Roswell Park Cancer Institute, Buffalo, New York, and the Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston

abstract

full text

219 kb

PEER VIEWPOINTS
Malignant Gastroparesis: Diagnostics and Therapeutics
Satish Nagula, MD, and Mark Schattner, MD, Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

full text

57 kb

The Riddle, Mystery, and Enigma of Gastroparesis
Pankaj Jay Pasricha, MD, Division of Gastroenterology and Hepatology, Stanford University, Stanford, California

full text

203 kb

Original Research

374

Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients: A Prospective Observational Study
Christopher M. Booth, MD, Mark Clemons, MD, George Dranitsaris, BPharm, MS, Anil Joy, MD, Scott Young, MD, Walter Callaghan, HBA, HBSc, Maureen Trudeau, MD, and Teresa Petrella, MD

Toronto Sunnybrook Regional Cancer Centre and Princess Margaret Hospital, Toronto, Canada; Cross Cancer Institute, Edmonton, Alberta, Canada; Northeastern Ontario Regional Cancer Centre, Sudbury, Canada

abstract

full text

148 kb

Quality-of-Life Outcomes

381

An Innovative Symptom Monitoring Tool for People With Advanced Lung Cancer: A Pilot Demonstration
Kimberly Davis, PhD, Susan Yount, PhD, Katie Del Ciello, BA, Margaret Whalen, RN, Shaheen Khan, MS, MBA, MPH, Mike Bass, MS, Hongyan Du, MS, David Eton, PhD, Gregory Masters, MD, Thomas Hensing, MD, and David Cella, PhD

Georgetown University Medical Center, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC; Center on Outcomes, Research and Education, Evanston, Illinois; Institute for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Learning Point Associates, Naperville, Illinois; Thomas Jefferson University Medical School, Philadelphia, Pennsylvania; and Medical Oncology Hematology Consultants, Helen F. Graham Cancer Center, Newark, Delaware

abstract

full text

130 kb

© 2007 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.